ZHAO Zhi-heng. Introduction and Inspiration of the Guidance on the Readability of European Union Package Leaflet[J]. Chinese Journal of Pharmacovigilance, 2012, 9(4): 207-210.
[1] European Commission,Guideline on the readability of the labeling and package leaflet of medicinal product for human use,revision 1 (12 January 2009)[S].http://ec.europa.eu/health/files/eudralex/vol-2/ c/2009-01-12_readability_guideline_final_en.pdf. [2] 国家食品药品监督管理局令第24号.药品说明书和标签管理规定[S].2006. [3] 朱玉华,张华锋,许静,等.药品说明书中存在的问题和建议[J].中国医药导报,2010,29(4):546-547. [4] Kurt Kinsey.Readability Testing of Package Information Leaflets and Bridging for the Generic Industry[R].http://www.pharma-eu.com/powerpoints/Kurt-Kinset-UT_11-2008.ppt. [5] European Commission,Pharmaceutical Legislation Medicinal Prod- ucts for Human Use.Directives2001/83/EC[S].http://ec.europa.eu/ 6 health/files/eudralex/vol-1/dir_2001_83_cons2009/2001_83_cons 7 2009_en.pdf. [6] European Commission,Guidance concerning consultations with target patient groups for the package leaflet[S].http://ec.europa.eu/health/files/eudralex/vol-2/c/user_consultation_200605_en.pdf. [7] EMEA,QRD convention to be followed for the EMA-QRD templates[S]. http://www.ema.europa.eu/docs/en_GB/document_library/ Regulatory_and_procedural_guideline/2009/10/WC500005091.pdf. [8] 卫生部医政司.关于征求对《全国防盲治盲工作规划(2006-2010年)》(征求意见稿)意见的函[S].http://www.moh.gov.cn/publicfiles/business/htmlfiles/mohyzs/s10596/200804/18928.htm.